Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Capsules, Wyeth-Ayerst NDA 20-151/S16, S19, S20, S21, S22, S23, S25 & 20-699/S14, S18, S21, S23, S26, S27, S34 1/31/03 2/12/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, 37.5 mg, 75 mg, and 150 mg, Wyeth-Ayerst NDA 20-699/S-015, S016, 20-151/S017, S018 5/2/01 7/30/03 4/25/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, 37.5 mg, 75 mg, and 150 mg, Wyeth-Ayerst NDA 20-699/S-032 2/26/03 3/10/03 Effexor, Wyeth-Ayerst NDA 20-151/S17 & S18 5/2/01 4/23/03 Effexor XR, Wyeth-Ayerst NDA 20-151/S15 & S16 5/2/01 Effexor Indications: Prevention o relapse and recurrence of depression. Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth-Ayerst NDA 20-699/S-022 2/11/03 2/12/03 2/13/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth-Ayerst NDA 20-699/S-029 10/22/02 10/28/02 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules. Wyeth-Ayerst Research NDA 20-699/S-001 3/11/99 3/22/99 3/22/99 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules. Wyeth-Ayerst Research NDA 20-699/S-038 & S-043 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharmaceuticals Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules, Wyeth Pharmaceuticals Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules,Wyeth Pharmaceuticals Effexor, Wyeth Pharmaceuticals, Inc., NDA 020699S030 Effexor (venlafaxine hydrochloride) Immediate Release Tablets & Extended Release Capsules, Wyeth Pharmaceuticals | Effexor (venlafaxine hydrochloride) Immediate Release, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine HCL) Extended-Release Capsules, Wyeth Pharma, Patient Population Altered | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor XR Extended Release capsule, Wyeth Pharma, Package Change | Venlafaxine Hydrochloride Tablets, Teva Pharma, Approval | Venlafaxine Hydrochloride Tablets, Mylan Pharma, Approval | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Venlafaxine Hydrochloride Tablets, Dr. Reddy’s Labs, Tentative Approval | Venlafaxine Hydrochloride Tablets, Zydus Pharma, Tentative Approval | Venlafaxine Hydrochloride Tablets, Sandoz Inc., Tentative Approval | Venlafaxine Hydrochloride Tablets, Pliva Hrvatska, Tentative Approval | Effexor (venlafaxine HCl) Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine HCl) Extended-Release Capsules, Wyeth Pharma, Labeling Revision | Venlafaxine Hydrochloride Extended-Release Capsules, Impax Labs, Tentative Approval | Effexor XR (venlafaxine HCl) Extended-Release Capsules, Wyeth Pharma, New Modified Indication | Effexor XR (venlafaxine HCl) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine HCl) Tablet, , Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine HCl) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine HCl) Immediate Release, Wyeth Pharma, Labeling Revision | Venlafaxine Hydrochloride Extended-Release Tablets, Osmotica Pharmaceutical Corp., Approval | Effexor (venlafaxine hydrochloride) Tablets, Wyeth Pharmaceuticals, Inc., Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended-Release Capsules, Wyeth Pharmaceuticals, Inc., Labeling Revision | Venlafaxine Hydrochloride Tablets, Caraco Pharmaceutical Laboratories, Ltd., Approval | Venlafaxine Hydrochloride Tablets, Mylan Pharmaceuticals, Inc., Approval | Venlafaxine Hydrochloride Tablets, Pliva Hrvatska, Approval | Venlafaxine Hydrochloride Tablets, Sandoz, Inc., Approval | Venlafaxine Hydrochloride Tablets, Zydus Pharmaceuticals USA, Inc., Approval | Venlafaxine Hydrochloride Extended-Release Capsules, Mylan Pharmaceuticals Inc., Tentative Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com